India to inspect six China manufacturers following GMP complaints

Related tags People's republic of china China

India to inspect six China manufacturers following GMP complaints
Chinese companies exporting drugs in bulk will come under the microscope next month when the Indian government sends a team of officials to inspect manufacturing plants.

The news follows a letter from India’s Central Drug Standard Control Organization (CDSCO) to the Chinese Food and Drug Authority (SFDA) querying complaints that some exporters did not hold GMP (good manufacturing practice) certificates.

An official from the Union Health Ministry told Times of India the SFDA also held suspicions, and requested CDSCO carry out some inspections.

Those reportedly coming under fire include SouthWest Synthetic Pharmaceutical Corporation in Chongqing, Suzhou Dawnrays Pharmaceuticals in Jiangsu Province, and InTec Products in Fujian Province.

More than 45% of bulk drug exporters registered in India are from China.

Related topics Ingredients QA/QC

Related news

Show more

Related product

Understanding the hidden value of quality

Understanding the hidden value of quality

Content provided by Thermo Fisher Scientific – Production Chemicals and Services | 16-Jan-2023 | White Paper

The raw material supply is too vital to leave to chance, and quality-related supply chain activities are cornerstones to your success.